MOESM3 of Muscle regulates mTOR dependent axonal local translation in motor neurons via CTRP3 secretion: implications for a neuromuscular disorder, spinal muscular atrophy
Supplementary Figures show the changes in serum creatinine levels and HFMSE at 6, 14, and 22 months of noxinaxin treatment, as well as the comparative efficacy of Crn, HFMSE, MRC, and 6MWT in evaluati
BackgroundSMA Type 1 is the most severe form of spinal muscular atrophy with early symptom onset, limited motor development, and poor prognosis. Recent genetic-based therapies, such as nusinersen, hav
